The Foreign Affairs Office of Hunan Provincial Party Committee conducted field research on the life science research and development center of Qankorey, and exchanged market development work at home and abroad.
2024-01-18
On the afternoon of January 18, 2024, Dai Zhiguang, deputy director of the Foreign Affairs Office of the Hunan Provincial CPC Committee, Zhang Ke, director of the Asia and Africa Division of the Foreign Affairs Office of the Hunan Provincial CPC Committee, Zheng Xi, deputy director of the Foreign Affairs Office of the Changsha Municipal CPC Committee, and other leaders of relevant provincial and municipal departments visited the Qankorey Life Science Research and Development Center.
The Foreign Affairs Office of the Provincial Party Committee conducted field research on the business layout, research and development investment, production base and channel construction of Qankorey Technology at home and abroad. Dai Zhengqian, chairman of the company, Professor Gu Baijun, chief scientist, Liu Ting, director of overseas marketing, Tao Zhengbang, minister of technology, and other leaders of relevant departments visited and exchanged together.
During the visit, Dai Zhiguang, deputy director of the Foreign Affairs Office of the Provincial Party Committee, focused on the production and research and development of Alzheimer's early screening products. Through the introduction of Tao Zhengbang, Minister of Technology, he learned more about the various aspects of the early screening product research and development. Project content, and give great affirmation and support. At the same time, for the expansion of Qankorey Technology in overseas markets, it also said that it will concentrate more industrial resources and continuously expand the promotion and sales of Alzheimer's early screening products in overseas markets.
Qankorey Technology has been focusing on the product research and development and layout of the whole industry chain of "prevention, screening, diagnosis and treatment" of Alzheimer's disease, and has exclusively developed Aβ monoclonal antibody. At present, the world's first international patent Alzheimer's disease early risk screening reagent based on urine detection of Aβ-urine beta amyloid protein detection kit has been successfully launched.
Qankorey Life Science Research and Development Center is the second phase of the Qankorey Science and Technology Research and Development and Production Base Project, with a number of 10,000-class clean workshops and 100,000-class clean workshops. After the launch of the research and development center, Qankorey science and technology will build a new mode of deep integration of production, teaching and research, open up a new track for high-quality development of the industry, focusing on deep cultivation of white blood cell antigen, somatic cell gene detection, macrophage diagnosis, traditional Chinese medicine decoction, polypeptide drugs and other product research and development, and quickly promote the transformation of scientific research results into productivity.
Through scientific and technological innovation, Qiankang Technology provides a full range of Alzheimer's disease solutions for Alzheimer's patients and families around the world, focusing on core technologies, integrating global resources, constantly exploring and innovating, and serving public health!
RELATED INFORMATION
Domestic business consulting:86-0731-85714218
Company E-mail:yingxiao@qankorey.com
International Business Consulting:86-18874232226
Company E-mail:lisa@qankorey.com
Company address: 12F, Building 15, 188 Middle Huanbao Road, Yuhua District, Changsha, Hunan , 410116, China
Production Address: 4th Floor, Building 7, Yuhua Intelligent Manufacturing Center, No.2 Hongda Road, Tongsheng Street, Yuhua District, Changsha, Hunan , 410000, China
Public Number
Small program
Jingdong
Taobao